FLT3 and leukemia: Azacitidine and cytarabine have the potential to induce differentiation of blasts, new targeted drugs like sorafenib (125) and midostaurin (126) may also be helpful in Fms-related tyrosine kinase 3 (FLT-3)-positive leukemia or panobinostat, an oral deacetylase inhibitor for MM (127, 128).